Jan Liliemark

Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.

William Plunkett, Jan Liliemark, Theresa M. Adams et al. · PubMed · 1987 · 160 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.

Gunnar Juliusson, Jan Liliemark · Journal of Clinical Oncology · 1993 · 143 citations

Medicine, Hematology, Pharmacology +10

On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.

Jan Liliemark, Freidoun Albertioni, Moustapha Hassan et al. · Journal of Clinical Oncology · 1992 · 130 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Response to 2-Chlorodeoxyadenosine in Patients with B-Cell Chronic Lymphocytic Leukemia Resistant to Fludarabine

Gunnar Juliusson, Annika Elmhorn‐Rosenborg, Jan Liliemark · New England Journal of Medicine · 1992 · 127 citations · Full text

Medicine, Oncology, Pharmacology +14

Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections

G Juliusson, Jan Liliemark · Blood · 1992 · 118 citations · Full text

Medicine, Hematology, Oncology +12